221 related articles for article (PubMed ID: 35990679)
1. Donor specific HLA antibody in hematopoietic stem cell transplantation: Implications for donor selection.
Krummey SM; Gareau AJ
Front Immunol; 2022; 13():916200. PubMed ID: 35990679
[TBL] [Abstract][Full Text] [Related]
2. The Role of HLA Antibodies in HLA Mismatched Allogeneic Hematopoietic Stem Cell Transplantation.
Zhang X; Wang J; Zhou Z; Zhang Y; Liu H; Tong C; Yu C; Lu Y; Zhao Y; Xiong M; Zhou JR; Juan S; Liu DY; Wei Z; Zhang J; Wu T; Lu DP
Clin Transpl; 2014; ():245-50. PubMed ID: 26281152
[TBL] [Abstract][Full Text] [Related]
3. [Effects of preexisting donor-specific HLA antibodies for graft failure in un-manipulated haploidentical hematopoietic stem cell transplantation].
Zhang RL; Zheng XH; Zhou LK; Zhang Y; Chen SL; Yang DL; Jiang EL; Wei JL; Huang Y; Ma QL; Zhai WH; Feng SZ; Han MZ; He Y
Zhonghua Xue Ye Xue Za Zhi; 2018 Mar; 39(3):190-195. PubMed ID: 29562462
[No Abstract] [Full Text] [Related]
4. Complement-Binding Donor-Specific Anti-HLA Antibodies and Risk of Primary Graft Failure in Hematopoietic Stem Cell Transplantation.
Ciurea SO; Thall PF; Milton DR; Barnes TH; Kongtim P; Carmazzi Y; López AA; Yap DY; Popat U; Rondon G; Lichtiger B; Aung F; Afshar-Kharghan V; Ma Q; Fernández-Viña M; Champlin RE; Cao K
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1392-8. PubMed ID: 25985919
[TBL] [Abstract][Full Text] [Related]
5. Results of haploidentical transplant in patients with donor-specific antibodies: a survey on behalf of the Spanish Group of Hematopoietic Transplant and Cell Therapy.
Bailén R; Alenda R; Herruzo-Delgado B; Acosta-Fleitas C; Vallés A; Esquirol A; Fonseca M; Solán L; Sánchez-Vadillo I; Bautista G; Bento L; López-Godino O; Pérez-Martínez A; Torrent A; Zanabili J; Calbacho M; Moreno MÁ; Pascual-Cascón MJ; Guerra-Domínguez L; Chinea A; García-Cadenas I; López-Corral L; Boix-Giner F; López Lorenzo JL; Humala K; Duarte R; Sampol A; Heras I; Vicario JL; Balas A; Oarbeascoa G; Fernández-Caldas P; Anguita J; Kwon M
Front Immunol; 2023; 14():1165759. PubMed ID: 37304258
[TBL] [Abstract][Full Text] [Related]
6. The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell Transplantation.
Ciurea SO; Cao K; Fernandez-Vina M; Kongtim P; Malki MA; Fuchs E; Luznik L; Huang XJ; Ciceri F; Locatelli F; Aversa F; Castagna L; Bacigalupo A; Martelli M; Blaise D; Handgretinger R; Roy DC; O'Donnell P; Bashey A; Lazarus HM; Ballen K; Savani BN; Mohty M; Nagler A
Bone Marrow Transplant; 2018 May; 53(5):521-534. PubMed ID: 29335625
[TBL] [Abstract][Full Text] [Related]
7. High-Dose immunoglobulin Intervention as an effective and simple strategy for donor specific Anti-HLA antibody desensitization in haploidentical transplant.
Zhu J; Wang Q; Liu Y; Dong Y; Liang Z; Yin Y; Liu W; Xu W; Sun Y; Wang B; Wang Q; Wang Q; Han N; Ren H; Li Y
Int Immunopharmacol; 2023 Jul; 120():110299. PubMed ID: 37201405
[TBL] [Abstract][Full Text] [Related]
8. On the role of HLA antibodies in hematopoietic stem cell transplantation.
Brand A; Doxiadis IN; Roelen DL
Tissue Antigens; 2013 Jan; 81(1):1-11. PubMed ID: 23216286
[TBL] [Abstract][Full Text] [Related]
9. Donor-Specific Anti-HLA Antibodies in Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide: Risk of Graft Failure, Poor Graft Function, and Impact on Outcomes.
Bramanti S; Calafiore V; Longhi E; Mariotti J; Crespiatico L; Sarina B; De Philippis C; Nocco A; Santoro A; Castagna L
Biol Blood Marrow Transplant; 2019 Jul; 25(7):1395-1406. PubMed ID: 30826463
[TBL] [Abstract][Full Text] [Related]
10. Risk and prevention of graft failure in patients with preexisting donor-specific HLA antibodies undergoing unmanipulated haploidentical SCT.
Yoshihara S; Maruya E; Taniguchi K; Kaida K; Kato R; Inoue T; Fujioka T; Tamaki H; Ikegame K; Okada M; Soma T; Hayashi K; Fujii N; Onuma T; Kusunoki Y; Saji H; Ogawa H
Bone Marrow Transplant; 2012 Apr; 47(4):508-15. PubMed ID: 21691261
[TBL] [Abstract][Full Text] [Related]
11. Anti-Hla Donor-Specific Antibodies Are Associated to Infection and Not to the Engraftment Rate in Outpatient Haploidentical Hematopoietic Cell Transplantation.
Jaime-Pérez JC; Cruz MLR; Mendoza-Ibarra SI; Moncada-Saucedo NK; Gómez-Almaguer D
Rev Invest Clin; 2023; 75(5):249-258. PubMed ID: 37918011
[TBL] [Abstract][Full Text] [Related]
12. Rebound and overshoot of donor-specific antibodies to human leukocyte antigens (HLA) during desensitization with plasma exchanges in hematopoietic progenitor cell transplantation: A case report.
Hassan S; West KA; Ward WW; Kanakry JA; Flegel WA
Transfusion; 2021 Jun; 61(6):1980-1986. PubMed ID: 33899963
[TBL] [Abstract][Full Text] [Related]
13. Evolution of HLA testing for hematopoietic stem cell transplantation: Importance of the candidate's antibody profile for donor selection.
Bettinotti MP
Hum Immunol; 2022 Oct; 83(10):721-729. PubMed ID: 35527083
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies.
Choe H; Gergis U; Hsu J; Phillips A; Shore T; Christos P; van Besien K; Mayer S
Biol Blood Marrow Transplant; 2019 Feb; 25(2):e60-e64. PubMed ID: 30661542
[TBL] [Abstract][Full Text] [Related]
15. Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant.
Bailén R; Vicario JL; Solán L; Sánchez-Vadillo I; Herrera P; Calbacho M; Alenda R; López-Lorenzo JL; Humala K; Chinea A; Sánchez-Pina J; Balas A; Moreno MÁ; Arzuaga J; Pradillo V; Dorado N; Oarbeascoa G; Anguita J; Díez-Martín JL; Kwon M
Front Immunol; 2021; 12():674658. PubMed ID: 34093576
[TBL] [Abstract][Full Text] [Related]
16. "Incidence and significance of donor-specific antibodies in haploidentical stem cell transplantation".
Altareb M; Al-Awwami M; Alfraih F; Alhayli S; Ahmed SO; Shaheen M; Chaudhri N; Alsharif F; Alkhabbaz H; Albabtain AA; Alfayez M; Hanbali A; Alshaibani A; Alotaibi AS; Rasheed W; Algharably A; Almohareb F; Alahmari A; Alzahrani H; Aljurf M; El Fakih R
Bone Marrow Transplant; 2023 Jun; 58(6):680-686. PubMed ID: 36959370
[TBL] [Abstract][Full Text] [Related]
17. Donor specific anti-HLA antibodies in hematopoietic stem cell transplantation. Single Center prospective evaluation and desensitization strategies employed.
La Rocca U; Perrone MP; Piciocchi A; Barberi W; Gesuiti P; Laurenti L; Cinti P; Gozzer M; Bafti MS; Carmini D; Cinelli N; Cavallari C; Giovannetti G; Ricci R; Girelli G; Foà R; Martelli M; Coluzzi S; Iori AP
Blood Transfus; 2024 Mar; 22(2):157-165. PubMed ID: 37847211
[TBL] [Abstract][Full Text] [Related]
18. High risk of graft failure in patients with anti-HLA antibodies undergoing haploidentical stem-cell transplantation.
Ciurea SO; de Lima M; Cano P; Korbling M; Giralt S; Shpall EJ; Wang X; Thall PF; Champlin RE; Fernandez-Vina M
Transplantation; 2009 Oct; 88(8):1019-24. PubMed ID: 19855248
[TBL] [Abstract][Full Text] [Related]
19. Presence of antibodies against HLA class I and class II molecules in children before and after allo-HSCT. Alloantibodies before and after HSCT.
Morán-Espinosa M; Angeles-Floriano T; Parra-Ortega I; Gaytán-Morales F; Castorena-Villa I; López-Martínez B; Ortiz-Navarrete V; Olvera-Gómez I
HLA; 2023 Jan; 101(1):16-23. PubMed ID: 36100956
[TBL] [Abstract][Full Text] [Related]
20. Combination treatment of rituximab and donor platelets infusion to reduce donor-specific anti-HLA antibodies for stem cells engraftment in haploidentical transplantation.
Zhang R; He Y; Yang D; Jiang E; Ma Q; Pang A; Zhai W; Wei J; Feng S; Han M
J Clin Lab Anal; 2020 Jul; 34(7):e23261. PubMed ID: 32112480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
